WELLS FARGO & COMPANY/MN - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 54 filers reported holding ENTRADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$84,167
-32.0%
5,327
-34.9%
0.00%
Q2 2023$123,845
+4952.8%
8,180
+4740.2%
0.00%
Q1 2023$2,451
+7.9%
169
+0.6%
0.00%
Q4 2022$2,271
-24.3%
168
+1.8%
0.00%
Q3 2022$3,000
+50.0%
165
+46.0%
0.00%
Q2 2022$2,000
-90.5%
113
-95.1%
0.00%
Q1 2022$21,000
-76.9%
2,285
-57.0%
0.00%
Q4 2021$91,0005,3200.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$8,042,56353.88%
MPM ASSET MANAGEMENT LLC 4,425,784$69,927,38737.45%
5AM Venture Management, LLC 4,408,379$69,652,38820.04%
StepStone Group LP 761,277$12,028,1772.68%
TCG Crossover Management, LLC 584,955$9,242,2891.36%
Redmile Group, LLC 1,284,000$20,287,2000.96%
Nan Fung Group Holdings Ltd 49,082$775,4960.63%
Baker Brothers Advisors 4,865,819$76,879,9400.44%
Corton Capital Inc. 10,485$165,6630.08%
CORNERCAP INVESTMENT COUNSEL INC 13,977$220,8370.04%
View complete list of ENTRADA THERAPEUTICS INC shareholders